Company Filing History:
Years Active: 1994
Title: The Innovative Contributions of Steven A. Krilis
Introduction
Steven A. Krilis is a notable inventor based in Hunter's Hill, Australia. He has made significant contributions to the field of medical diagnostics, particularly in the detection of antiphospholipid antibodies. His work has implications for understanding autoimmune diseases and infectious diseases.
Latest Patents
Krilis holds a patent for "Methods for determining anti-phospholipid and anti-cardiolipin antibodies." This innovative method involves contacting a sample with a negatively charged phospholipid and with β-2-glycoprotein-I or a homolog or analog thereof. The method determines whether any antiphospholipid antibodies have bound to the contacted phospholipid and β-2-glycoprotein-I. Detection of this binding indicates the presence of antiphospholipid antibodies in the sample. Additionally, the patent includes methods for determining the presence of negatively charged phospholipids and kits for assays related to these antibodies.
Career Highlights
Steven A. Krilis is associated with Yamasa Shoyu Kabushiki Kaisha, where he continues to contribute to innovative research and development. His work has garnered attention for its potential impact on medical diagnostics and treatment strategies.
Collaborations
Krilis has collaborated with notable colleagues, including Hugh P. McNeill and Colin N. Chesterman. These collaborations have furthered the research and development of diagnostic methods in the medical field.
Conclusion
Steven A. Krilis exemplifies the spirit of innovation in medical diagnostics through his patented methods for detecting antiphospholipid antibodies. His contributions are vital for advancing our understanding of autoimmune and infectious diseases.